Comparative clinical study of Cefteram pivoxil (CFTM-PI) with Cefaclor (CCL) in the treatment of odontogenic infections.

DOI
  • SASAKI JIRO
    Department of Oral Surgery, School of Medicine, Tokai University
  • KANEKO AKIHIRO
    Department of Oral Surgery, School of Medicine, Tokai University
  • SHIIKI KAZUO
    Department of Dentistry and Oral Surgery, Iwaki Kyoritu General Hospital
  • SUGANO KAZUYUKI
    Department of Dentistry and Oral Surgery, Iwaki Kyoritu General Hospital
  • SAKAMOTO HARUO
    Department of Dentistry and Oral Surgery, Ashikaga Red Cross Hospital
  • SATOH TAZUKO
    The Nippon Dental University, School of Dentistry at Tokyo, Department of Oral and Maxillofacial Surgery 1
  • MIYASAKA TAKAHIRO
    The Nippon Dental University, School of Dentistry at Tokyo, Department of Oral and Maxillofacial Surgery 1
  • MICHI KEN-ICHI
    First Department of Oral and Maxillofacial Surgery, School of Dentistry, Showa University
  • YOSHIDA HIROSHI
    First Department of Oral and Maxillofacial Surgery, School of Dentistry, Showa University
  • OSONE YOU
    Department of Dentistry, Tokyo Metropolitan Bokuto General Hospital
  • KONNAI TOSHIKATSU
    Department of Dentistry and Oral Surgery, National Tosei Hospital
  • YAMAMOTO TADASHI
    Department of Dentistry and Oral Surgery, Toyohashi Municipal Hospital
  • KANOH YOSHINORI
    Department of Dentistry and Oral Surgery, Toyohashi Municipal Hospital
  • HATTORI TAKANORI
    Second Department of Oral and Maxillofacial Surgery, School of Dentistry, Aichi-Gakuin University
  • NARITA TAKANORI
    Second Department of Oral and Maxillofacial Surgery, School of Dentistry, Aichi-Gakuin University
  • SUGIMURA MASAHITO
    Department of Oral and Maxillofacial Surgery, Nara Medical College
  • UEMURA KAZUYOSHI
    Department of Oral and Maxillofacial Surgery, Nara Medical College
  • FUJII NOBUO
    Department of Oral Surgery, Okinawa Prefectual Chubu Hospital
  • DEGUCHI KOUICHI
    Laboratory Section, Tokyo Clinical Research Center
  • OGAWA NOBUYA
    Department of Pharmacology, Ehime University, School of Medicine

Bibliographic Information

Other Title
  • 急性歯性感染症に対する　Ｃｅｆｔｅｒａｍ　ｐｉｖｏｘｉｌ　（ＣＦＴＭ‐ＰＩ）とＣｅｆａｃｌｏｒ　（ＣＣＬ）の薬効比較試験成績

Search this article

Description

The clinical efficacy, side effects and clinical usefulness of Cefteram pivoxil (CFTM-PI) were compared with dose of Cefaclor (CCL) by a double-blind method in the treatment of oral infections. Since the need explanation, what does it mean by test compound were odontogenic antibacterial agents, the target diseases were limited to periodontal infections, pericoronitis and osteitis of jaw. Drugs were administered for 3-7 days at doses of 200mg t, i. d. (CFTM-PI) and 250 mg t.i.d. (CCL) . A total of 248 cases were included in this study.<BR>Results obtained were as follows:<BR>1) The clinical efficacy was evaluated by the doctors-in-charge in 245 cases (123 in the CFTM-PI group and 122 in the CCL group) and the numerical rating on the 3 rd day of treatment in 245 cases (123 in the CFTM-PI group and 122 in the CCL group) .<BR>The clinical efficacy rate according to the doctors-in-charge was 84.5 % for the CFTM-PI group and 79.5 % for the CCL group. The evaluation of the numerical rating was 88.7 % for the CFTM-PI group and 80.9 % for the CCL group.<BR>There was no significant difference found in tems of clinical effectiveness between the two groups by using these two methods of clinical diagnosis.<BR>2) Some side effects were discovered in 5 cases (4.1 % of 122) treated with CFTM-PI and in 4 cases (3.3 % of 120) treated with CCL, but no severe symptoms were observed. Abnormal changes found in the laboratory were noted as 9.1 % in the CFTM-PI group and 14.5 % in the CCL group.<BR>There was no significant difference in terms of safety between the two groups.<BR>3) Similarly, in terms of clinical usefulness, there was no significant difference between these two groups.<BR>From these results, it is concluded that CFTM-PI is as effective as CCL in the treatment of odontogenic infections.

Journal

Keywords

Details 詳細情報について

Report a problem

Back to top